Focused Ultrasound in the UK

Focused ultrasound is an early-stage, noninvasive therapeutic technology with the potential to impact countless patients. Clinicians and researchers in the UK were among the early adopters of this technology and have championed its use for many disorders.

Research, Development, and Commercialization

There are currently 34 focused ultrasound indications in various stages of development in the UK, and more than 170 across the globe. Thirty-two have regulatory approval worldwide, and 13 have achieved CE Marking in the UK.

Research and Clinical Sites in the Region

In the UK, there are 16 research sites, 23 clinical sites, and 2 Focused Ultrasound Centers of Excellence. Four manufacturers are also located in the UK.

Focused Ultrasound Companies in the UK

There are nine clinical therapeutic ultrasound systems being used to treat the following indications: 

• Sonablate Corporation’s Sonablate system – prostate tumors 
• EDAP TMS Ablatherm system – prostate tumors 
• Profound Medical’s TULSA-PRO system – prostate tumors 
• Chongqing HAIFU’s JC200 system – multiple soft tissue/abdominal organs 
• Theraclion’s Sonovein system – varicose veins 
• Insightec’s Exablate Neuro system – essential tremor, Parkinson’s disease 
• OxSonics Therapeutics* – colorectal cancer metastasis to the liver 
• Exact Therapeutics* – colorectal cancer metastasis to the liver 
• Histosonics* – kidney cancer 

*In clinical trials; does not have regulatory approval.